The Flagship Initiative, launched by Innosuisse, drives innovation and foster transdisciplinary collaboration. Focus on solutions that require the cooperation of multiple stakeholders, encouraging projects that contribute to CH's future well-being with innovative solutions and business models.
AI has innovated in key human health areas such as drug discovery, genomic data analysis, precision and personalized medicine, multimodal large language models, and protein language models. Switzerland can lead in developing AI solutions to address challenges and add value to human health.
A consortium must include at least three research partners (one University of Applied Sciences) and two implementation partners. In exceptional cases, two research partners are acceptable.
Key components include: - Systemic Innovation: integrating complementary innovations to create new value. - Transdisciplinary Collaboration: involving actors from various disciplines to tackle complex challenges. - Broad Topics: addressing critical areas for Switzerland’s future.
Innovation: novelty in scientific, economic, and societal domains. Value Creation: market competitiveness and social/economic well-being in CHFlagship Setup: quality methods, clear goals, defined roles. Expertise: expertise and transdisciplinary structure. Cost-Benefit: analysis of cost/benefits
July 2024 – Launch of the call 2024 12 November 2024 – Deadline for submitting mandatory pre-proposal February 2025 – Recommendation letters to applicants 7 May 2025 – Deadline for submitting proposal July 2025 – Decision letters to applicants
Have a look at projects approved at the last call. The Innosuisse platforms allows you to overwiev the ongoing projects.
